As PEAK1/2 can mediate TK signaling induced by growth factor receptors [4,5], the absence of association between PEAK3 and the oncogenic receptor TK FLT3-TD in AML [28] is surprising. The gene discussed is PEAK1; the disease is acute myeloid leukemia.